OPA0 Stock Overview
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Orpea SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €6.80 |
| 52 Week High | €8.10 |
| 52 Week Low | €3.94 |
| Beta | 0.97 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -15.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPA0 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | -1.2% |
| 1Y | n/a | -6.5% | 1.2% |
Return vs Industry: Insufficient data to determine how OPA0 performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how OPA0 performed against the German Market.
Price Volatility
| OPA0 volatility | |
|---|---|
| OPA0 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: OPA0 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OPA0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 71,000 | Laurent Guillot | www.orpea-corp.com |
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company’s post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state.
Orpea SA Fundamentals Summary
| OPA0 fundamental statistics | |
|---|---|
| Market cap | €442.32m |
| Earnings (TTM) | -€306.54m |
| Revenue (TTM) | €4.52b |
0.1x
P/S Ratio-1.5x
P/E RatioIs OPA0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPA0 income statement (TTM) | |
|---|---|
| Revenue | €4.52b |
| Cost of Revenue | €3.53b |
| Gross Profit | €995.99m |
| Other Expenses | €1.30b |
| Earnings | -€306.54m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.74 |
| Gross Margin | 22.02% |
| Net Profit Margin | -6.78% |
| Debt/Equity Ratio | 256.1% |
How did OPA0 perform over the long term?
See historical performance and comparison